pharma · Duchenne Muscular Dystrophy · Gastroparesis · PCSA
Processa Pharmaceuticals
Processa Pharmaceuticals patent portfolio — 0 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Hanover, USA HQ
16 Employees
Public company Type
PCSA · NYSE Ticker
Company details
- Status
- Public
- HQ
- Hanover, USA
- Employees
- 16
- Programs
- 8
- Drugs
- 2
- Patents
- 0
Processa Pharmaceuticals patents
0 pharmaceutical patents indexed for Processa Pharmaceuticals. 0 expire within 24 months.
Processa Pharmaceuticals has 0 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
No patents matched
Frequently asked questions
How many patents does Processa Pharmaceuticals have?
0 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Processa Pharmaceuticals patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.